Sutro Biopharma STRO Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $58.13M-69.5% | $190.3M+175% | $69.27M+46.6% | $47.25M+55.4% | ||
| $83.3M-34.2% | $126.59M-52.1% | $264.41M+3.7% | $255.09M+95.7% | ||
| $3.98M-53.8% | $8.62M-76.1% | $36.08M+407% | $7.12M-42.8% | ||
| $150.93M-56.0% | $343.31M-18.6% | $421.54M+19.4% | $353.15M+61.6% | ||
| $10.65M-41.5% | $18.19M-17.1% | $21.94M-10.9% | $24.62M+9.2% | ||
| $173.83M-55.1% | $387.21M-17.7% | $470.74M+15.7% | $406.94M+19.2% | ||
| $7.57M-27.8% | $10.48M+11.0% | $9.44M+96.8% | $4.8M-20.2% | ||
| $10.56M-84.9% | $69.78M+238% | $20.67M+23.3% | $16.76M+205% | ||
| $75.13M-43.0% | $131.89M+40.7% | $93.75M+40.9% | $66.55M+59.4% | ||
| $306.28M-10.6% | $342.61M+6.7% | $321.09M+69.1% | $189.9M+114% | ||
| $9K+12.5% | $8K-86.9% | $61K+5.2% | $58K+26.1% | ||
| -$977.96M-24.3% | -$786.87M-40.7% | -$559.41M-23.6% | -$452.62M-35.8% | ||
| -$132.45M-397% | $44.6M-70.2% | $149.65M-31.1% | $217.05M-14.1% | ||
| $173.83M-55.1% | $387.21M-17.7% | $470.74M+15.7% | $406.94M+19.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Sutro Biopharma's total assets?
- Sutro Biopharma (STRO) holds $242.0M in total assets, down 24.7% year over year.
- How much debt does Sutro Biopharma have?
- Sutro Biopharma carries $13.6M in total debt against -$66.9M of shareholders' equity, a debt-to-equity ratio of 0.52.
- How much cash does Sutro Biopharma have?
- Sutro Biopharma holds $73.7M in cash and equivalents.
- Can Sutro Biopharma cover its short-term obligations?
- Its current ratio is 3.12 — current assets exceed current liabilities.
- Where does Sutro Biopharma's balance sheet data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
